1 April 2004
Lawrence plc
Update on Aivlosin Registration
Following the meeting of the EMEA Committee for Veterinary Medicinal
Products (CVMP) on 17 March we have been given a timetable which advises
us that an official CVMP opinion will be given early in May which may
lead to a full European registration by the end of June 2004. In which
case, ECO is expecting to start marketing Aivlosin in Europe in the
second half of this year.
Contacts:
Peter Lawrence
Chairman, Lawrence plc
020 8336 2900
Anthony Spiro
Spiro Financial
020 8949 0428
Philip Davies
Charles Stanley & Co. Limited
020 7953 2000
Lawrence plc is a leader in the development, manufacture and
distribution of principally specialist chemical and pharmaceutical
products for the animal health and farming markets worldwide. Our
products for these growth markets incorporate natural ingredients to
promote well being and sustainability. We achieve our financial goals
through the careful and responsible application of science to generate
value for our shareholders.
Our corporate web site www.lawrenceplc.com includes our press releases
together with general information about the company and its
subsidiaries. Each subsidiary also has a web site, which gives further
information about that business and its products.